The Royal Preston Hospital or RPH, is an acute general hospital in Preston, Lancashire, England. It is managed by the Lancashire Teaching Hospitals NHS Foundation Trust.

During the past decade, Royal Preston Hospital conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 15 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 13 clinical trials were completed. i.e. 59.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Preston Hospital" #1 sponsor was "Hoffmann-La Roche" with 11 trials, followed by "Medical Research Council" with 7 trials sponsored, "Institute of Cancer Research, United Kingdom" with 5 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 4 trials sponsored and "University College, London" with 4 trials sponsored. Other sponsors include 57 different institutions and companies that sponsored additional 59 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Preston Hospital" #1 collaborator was "Cancer Research UK" with 6 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator, "Celgene" with 2 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials as a collaborator and "NHS Lothian" with 2 trials as a collaborator. Other collaborators include 50 different institutions and companies that were collaborators in the rest 59 trials.

According to Clinical.Site data, the most researched conditions in "Royal Preston Hospital" are "Breast Cancer" (8 trials), "Bladder Cancer" (4 trials), "Atrial Fibrillation" (3 trials), "COVID-19" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Royal Preston Hospital" in a lesser frequency.

Most popular intervention types in "Royal Preston Hospital" are "Drug" (57 trials), "Other" (14 trials), "Radiation" (14 trials), "Biological" (12 trials) and "Procedure" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "radiation therapy" (7 trials), "cyclophosphamide" (5 trials), "fluorouracil" (5 trials) and "Atezolizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Royal Preston Hospital" are 77 trials for "All" genders, 10 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Royal Preston Hospital". undefined are not yet recruiting, 16 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 47 completed trials in Royal Preston Hospital, 2 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Preston Hospital, 4 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 11 trials that are defined as “Not Applicable".

Royal Preston Hospital has several departments that took part in Clinical trials: "Greenwood Medical Center" - 4 trials, "Oak Lodge Medical Centre" - 2 trials, "St Chad's Surgery" - 2 trials